Hepatitis C: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
m (Text replacement - "g| authorlink" to "g | author-link")
 
(47 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Hepatitis C''' ('''HCV''' or '''Hep C''') is a disease caused by an [[RNA]] [[virus]] that affects approximately 170 million people worldwide<ref name="Siu2016" /> and is most often known for its associations with liver damage.
'''Hepatitis C''' ('''HCV''' or '''Hep C''') is a disease caused by an [[RNA]] [[virus]] that affects approximately 170 million people worldwide<ref name="Siu2016">{{citation | last1 = Siu | first1 = Gavin Ka Yu | authorlink1 = | last2 = Zhou | first2 = Fan | authorlink2 = | last3 = Yu | first3 = Mei Kuen | authorlink3 = | last4 = Zhang | first4 = Leiliang | author-link4 = | last5 = Wang | first5 = Tuanlao| authorlink5 = | last6 = Liang | first6 = Yongheng | author-link6 = | last7 = Chen | first7 = Yangchao| authorlink7 = | last8 = Chan | first8 = Hsiao Chang | authorlink8 = | last9 =Yu | first9 = Sidney | author-link9 =  | title = Hepatitis C virus NS5A protein cooperates with phosphatidylinositol 4-kinase IIIα to induce mitochondrial fragmentation | journal = Scientific Reports 6 | year = 2016 | doi = 10.1038/srep23464 | url = http://www.nature.com/articles/srep23464 }}</ref> and is most often known for its associations with liver damage.<ref name="WHO2015">{{citation | title=Hepatitis C  Fact sheet N°164 | url = http://www.who.int/mediacentre/factsheets/fs164/en/|website=WHO|access-date=4 February 2016 | date = July 2015}}</ref>


Hepatitis C incidence has been shown to be increased in [[chronic fatigue syndrome]] patients.
Hepatitis C incidence has been shown to be increased in [[chronic fatigue syndrome]] patients.{{citation needed | date = Jul 2020}}


==Prevalence==
==Prevalence==
It is estimated that between 130-200 million people worldwide have a hepatitis C infection, occurring most commonly in Africa and Central and East Asia.<ref name="WHO2015" /> In 2013, hepatitis C was the cause of around 358,000 deaths due to cirrhosis and 343,000 deaths due to liver cancer.<ref name="GBD204" />
It is estimated that between 130-200 million people worldwide have a hepatitis C infection, occurring most commonly in Africa and Central and East Asia.<ref name="WHO2015" /> In 2013, hepatitis C was the cause of around 358,000 deaths due to cirrhosis and 343,000 deaths due to liver cancer.<ref name="GBD204">{{citation | last1 = GBD 2013 Mortality and Causes of Death | first1 = Collaborators | title = Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013.|journal=Lancet | date = 17 December 2014|pmid=25530442|doi=10.1016/S0140-6736(14)61682-2|volume=385|issue=9963|pages=117–71|pmc=4340604}}</ref>


==Transmission==
==Transmission==
Line 13: Line 13:


==Hepatitis C in Chronic Fatigue Syndrome==
==Hepatitis C in Chronic Fatigue Syndrome==
==Notable studies==
==Notable studies==


==Potential treatments==
==Potential treatments==


==Learn more==
== See also ==
*[https://en.wikipedia.org/wiki/Hepatitis_C Wikipedia - Hepatitis C]
 
== Learn more ==
*[http://www.who.int/mediacentre/factsheets/fs164/en/ Factsheet] - World Health Organization


==References==
== References ==
<ref name="Siu2016">{{citation
{{Reflist}}
| last1  = Siu      | first1 = Gavin Ka Yu        | authorlink1 =
| last2  = Zhou    | first2 = Fan                | authorlink2 =
| last3  = Yu      | first3 = Mei Kuen            | authorlink3 =
| last4  = Zhang    | first4 = Leiliang            | authorlink4 =
| last5  = Wang    | first5 = Tuanlao            | authorlink5 =
| last6  = Liang    | first6 = Yongheng            | authorlink6 =
| last7  = Chen    | first7 = Yangchao            | authorlink7 =
| last8  = Chan    | first8 = Hsiao Chang        | authorlink8 =
| last9  = Yu      | first9 = Sidney              | authorlink9 =
| title  = Hepatitis C virus NS5A protein cooperates with phosphatidylinositol 4-kinase IIIα to induce mitochondrial fragmentation
| journal = Scientific Reports 6 | year = 2016 |
| doi    = 10.1038/srep23464
| url    = http://www.nature.com/articles/srep23464
}}</ref>
<ref name="WHO2015">{{citation|title=Hepatitis C  Fact sheet N°164|url=http://www.who.int/mediacentre/factsheets/fs164/en/|website=WHO|accessdate=4 February 2016|date=July 2015}}</ref>
<ref name="GBD204">{{citation|last1=GBD 2013 Mortality and Causes of Death|first1=Collaborators|title=Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013.|journal=Lancet|date=17 December 2014|pmid=25530442|doi=10.1016/S0140-6736(14)61682-2|volume=385|issue=9963|pages=117–71|pmc=4340604}}</ref>
<references />


[[Category:Triggers and risk factors]]
[[Category:Triggers and risk factors]]

Latest revision as of 01:47, April 2, 2023

Hepatitis C (HCV or Hep C) is a disease caused by an RNA virus that affects approximately 170 million people worldwide[1] and is most often known for its associations with liver damage.[2]

Hepatitis C incidence has been shown to be increased in chronic fatigue syndrome patients.[citation needed]

Prevalence[edit | edit source]

It is estimated that between 130-200 million people worldwide have a hepatitis C infection, occurring most commonly in Africa and Central and East Asia.[2] In 2013, hepatitis C was the cause of around 358,000 deaths due to cirrhosis and 343,000 deaths due to liver cancer.[3]

Transmission[edit | edit source]

Signs and symptoms[edit | edit source]

Diagnosis[edit | edit source]

Hepatitis C in Chronic Fatigue Syndrome[edit | edit source]

Notable studies[edit | edit source]

Potential treatments[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. Siu, Gavin Ka Yu; Zhou, Fan; Yu, Mei Kuen; Zhang, Leiliang; Wang, Tuanlao; Liang, Yongheng; Chen, Yangchao; Chan, Hsiao Chang; Yu, Sidney (2016), "Hepatitis C virus NS5A protein cooperates with phosphatidylinositol 4-kinase IIIα to induce mitochondrial fragmentation", Scientific Reports 6, doi:10.1038/srep23464
  2. 2.0 2.1 "Hepatitis C Fact sheet N°164", WHO, July 2015, retrieved February 4, 2016
  3. GBD 2013 Mortality and Causes of Death, Collaborators (December 17, 2014), "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013.", Lancet, 385 (9963): 117–71, doi:10.1016/S0140-6736(14)61682-2, PMC 4340604, PMID 25530442